3-5
2026
影响因子区间
—
平台估算
13%
2025
中国作者发文占比
2760 USD;2270 GBP;2610 EUR
收费
期刊简介:Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.The Editors welcome:Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data.Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug.The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.
【译文】关于药物代谢与毒性的专家意见(ISSN 1742-5255 [印刷版],1744-7607 [电子版])是一本MEDLINE索引、同行评审的国际期刊,发表关于ADME-Tox所有方面的综述文章。每篇文章的结构都旨在融入作者对未来发展范围的自身专家意见。编辑们欢迎:涵盖特定药物、药物相互作用、药物类别或其在特定人群中使用相关的代谢、药代动力学和毒理学问题的综述;涉及参与药物代谢、处置和排泄的酶的问题;涉及药物代谢和毒理学研究的技术;获取ADME-Tox数据的新技术。对特定药物的临床、毒理学和药代动力学数据进行评估的药物评估。读者包括制药行业的科学家和管理人员、药理学家、临床毒理学家和相关专业人士。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 3区 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |